Disclosure 0001178913-26-004715-1

SEC FORM 4

$1,431.00

RedHill Biopharma Ltd. (RDHL)

Sale of 14,310,000 shares at $0.0001 per share.

Reporting Person Raday Gilead · Officer Title Chief Operating Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 6, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001178913-26-004715 · filed 2026-10-06 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "RedHill Biopharma Ltd. (RDHL)." Disclosed 2026-10-06. https://desqlong.com/cards/0001178913-26-004715-1 (retrieved 2026-10-07).